{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-017744","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.323129+00:00","generated_at":"2026-06-02T23:11:40.146930+00:00","sec_items":["3.01","3.02","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Biotricity faces Nasdaq delisting for missing annual meeting; closes $354k private placement","bullets":["Nasdaq notified Biotricity on May 1, 2024 of non-compliance with annual meeting rule; additional delisting basis.","Company must respond to Nasdaq Hearings Panel by May 8, 2024; intends to hold meeting as soon as practicable.","On April 30, 2024, closed second tranche of private placement: 39 Series B Preferred shares for $354,545.","Registration Rights Agreement filed; failure to file or obtain effectiveness triggers 100,000 common shares per event."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-017744","json":"https://secwatch.observer/filing/0001493152-24-017744.json","markdown":"https://secwatch.observer/filing/0001493152-24-017744.md","text":"https://secwatch.observer/filing/0001493152-24-017744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224017744/0001493152-24-017744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224017744/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:11:40.146930+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83748a3113ec0772a9feaf35d3f1ae30eb709e83","claim":"BIOTRICITY INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).","evidence_excerpt":"May 1, 2024, Biotricity Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that it is not in compliance with the Nasdaq Listing Rule 5620(a) (the “Rule”) requiring that the Company hold an annual meeting of stockholders within 12 months of the end of its fiscal year. The notification received has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to its compliance with the other continued listing requirements. In the letter dated May 1, 2024, Nasdaq notified the Company that this serves as an additional basis for del","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224017744/0001493152-24-017744-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Rules","value":"5620(a)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}